Mark Mullikin | Senior Director, Finance and Investor Relations |
Katrine Bosley | CEO, President and Director |
Andrew Hack | CFO |
Charles Albright | Chief Scientific Officer |
Vic Myer | CTO |
Philip Nadeau | Cowen and Company |
Good afternoon and welcome to Editas Medicine’s Third Quarter 2017 Financial Results and Update Conference Call. [Operator Instructions]. Please be advised that this call is being recorded at Editas Medicine’s request. I would now like to turn the call over to the Editas Medicine team. Please proceed.